124. 皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症
[臨床試験数:11,薬物数:13(DrugBank:4),標的遺伝子数:3,標的パスウェイ数:11

Searched query = "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", "CADASIL", "Autosomal dominant cerebral artery disease w ... show all
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04334408
(ClinicalTrials.gov)
January 20212/4/2020Safety and Efficacy of Fremanezumab for Migraine in Adult CADASILA Phase II Double-Blinded Placebo Controlled Individual Subject Stepped Wedge Clinical Trial Evaluating the Safety and Efficacy of Fremanezumab for Migraine in Adult CADASILCadasil;MigraineDrug: Fremanezumab;Drug: PlaceboMayo ClinicNULLNot yet recruiting18 Years70 YearsAll5Phase 2United States